ERBB2 and gastric cancer: The association of HER2 with a specific type suggests that intestinal- and diffuse-type gastric cancers develop along different molecular pathways and supports earlier studies showing distinct patterns of genetic alterations in gastric cancers of differing histopathologic features [85].